Incorporating direct-to-consumer genomic information into patient care: attitudes and experiences of primary care physicians

Author:

Bernhardt Barbara A1,Zayac Cara2,Gordon Erynn S3,Wawak Lisa3,Pyeritz Reed E42,Gollust Sarah E5

Affiliation:

1. Division of Translational Medicine & Human Genetics, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, Penn Tower Room 1115, Philadelphia, PA 19104, USA.

2. Penn Center for the Integration of Genetic Healthcare Technologies, University of Pennsylvania, Philadelphia, PA 19104, USA

3. Coriell Institute for Medical Research, Camden, NJ 08103, USA

4. Division of Translational Medicine & Human Genetics, Perelman School of Medicine, University of Pennsylvania, 3400 Spruce Street, Penn Tower Room 1115, Philadelphia, PA 19104, USA

5. Division of Health Policy & Management, University of Minnesota School of Public Health, Minneapolis, MN 55455, USA

Abstract

Aim: Despite predictions of increased clinical applications, little is known about primary care providers’ (PCPs’) readiness to apply genomics to patient care. The aim was to assess PCPs’ current experience with genetic testing, their assessment of the understandability and clinical utility of information in sample direct-to-consumer reports for genomic assessment of disease risk and warfarin dosing and attitudes toward genomic medicine. Materials & methods: A web-based survey of PCPs who are members of Knowledge Networks’ Physician Consulting Network was conducted. Results: Of the 502 respondents (23.3% response rate), most ordered genetic tests infrequently. When presented with the direct-to-consumer genomic testing reports, most believed the reports were understandable, and would be willing to review results with a patient, and many believed the results would be helpful in patient management. Conclusion: Despite limited experience with genetic tests, PCPs are open to helping patients understand genomic information. However, additional physician education is needed.

Publisher

Future Medicine Ltd

Subject

Pharmacology,Molecular Medicine,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3